The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain—from donor, through collection and processing, to patients—to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic.

Additional Metadata
Persistent URL dx.doi.org/10.1016/S2352-3026(20)30186-1, hdl.handle.net/1765/128969
Journal The Lancet Haematology
Citation
Stanworth, S, New, H.V. (Helen V), Apelseth, T.O. (Torunn O), Brunskill, S. (Susan), Cardigan, R. (Rebecca), Doree, C. (Carolyn), … Thachil, J. (Jecko). (2020). Effects of the COVID-19 pandemic on supply and use of blood for transfusion. The Lancet Haematology. doi:10.1016/S2352-3026(20)30186-1